Literature DB >> 15205214

Irinotecan chemotherapy associated with transient dysarthria and aphasia.

S De Marco, E Squilloni, L Vigna, M F Bertagnolio, C N Sternberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15205214     DOI： 10.1093/annonc/mdh277

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Authors:  Ayumu Matsuoka; Osamu Maeda; Megumi Inada-Inoue; Eizaburo Ohno; Yoshiki Hirooka; Yukihiro Yokoyama; Tsutomu Fujii; Masato Nagino; Hidemi Goto; Yuichi Ando
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

3.  Irinotecan-induced dysarthria: an insight into its pathogenesis?

Authors:  Jesus A Gomez; Ines Sanchez; Jose A Ramirez
Journal:  Gastrointest Cancer Res       Date:  2008-07

Review 4.  FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Authors:  Krishna S Gunturu; Xiaopan Yao; Xiangyu Cong; Jaykumar R Thumar; Howard S Hochster; Stacey M Stein; Jill Lacy
Journal:  Med Oncol       Date:  2012-12-28       Impact factor: 3.064

5.  Irinotecan-induced dysarthria.

Authors:  Albertine J Dressel; Johannes C van der Mijn; Ijke J Aalders; Rico N P M Rinkel; Hans J van der Vliet
Journal:  Case Rep Oncol       Date:  2012-01-18

6.  Severe Generalized Weakness, Paralysis, and Aphasia following Administration of Irinotecan and Oxaliplatin during FOLFIRINOX Chemotherapy.

Authors:  Manisha Chandar; Robert de Wilton Marsh
Journal:  Case Rep Oncol       Date:  2015-03-04

Review 7.  Pancreatic cancer and FOLFIRINOX: a new era and new questions.

Authors:  Robert De W Marsh; Mark S Talamonti; Matthew Harold Katz; Joseph M Herman
Journal:  Cancer Med       Date:  2015-02-19       Impact factor: 4.452

8.  A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy.

Authors:  Laura Attademo; Stefano De Falco; Mario Rosanova; Marcello Esposito; Federica Mazio; Francesca Foschini; Antonio Santaniello; Giovanni Fiore; Elide Matano; Fiore Manganelli; Chiara Carlomagno
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

9.  Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience.

Authors:  Ali Elbeddini; Naushin Hooda; Mohamed Gazarin; Penny Webster; Jackie McMillan
Journal:  Am J Case Rep       Date:  2020-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.